Hemophagocytic Lymphohistiocytosis and Kawasaki disease: Combined manifestation and differential diagnosis
Titze U, Janka G, Schneider EM, et al. Hemophagocytic Lymphohistiocytosis and Kawasaki disease: Combined manifestation and differential diagnosis. Pediatr Blood Cancer 2009;53:493-495.
Kawasaki disease preceding haemophagocytic lymphohistiocytosis: Challenges for developing world practitioners
Hendricks M, Pillay S, Davidson A, et al. Kawasaki disease preceding haemophagocytic lymphohistiocytosis: Challenges for developing world practitioners. Pediatr Blood Cancer 2010;54:1023-1025.
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Vastert SJ, van Wijk R, D'Urbano LE, et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology 2010;49:441-449.
Macrophage activation syndrome in juvenile systemic lupus erythematosus: A multinational multicenter study of thirty-eight patients
Parodi A, Davì S, Pringe AB, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: A multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009;60:3388-3399.
The hemophagocytic syndrome/macrophage activation syndrome: A final common pathway of a cytokine storm
Szyper-Kravitz M. The hemophagocytic syndrome/macrophage activation syndrome: A final common pathway of a cytokine storm. Isr Med Assoc J 2009;11:633-634.
The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age
Stabile A, Bertoni B, Ansuini V, et al. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. Eur Rev Med Pharmacol Sci 2006;10:53-59. (Pubitemid 43676430)